CCGA Workgroup: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 42: | Line 42: | ||
|Krysiak | |Krysiak | ||
|Washington University | |Washington University | ||
|- | |- | ||
|Fei | |Fei | ||
| Line 106: | Line 102: | ||
|Burnside | |Burnside | ||
|University of Florida | |University of Florida | ||
|- | |- | ||
|Ngonidzashe | |Ngonidzashe | ||
| Line 118: | Line 110: | ||
|Thurston | |Thurston | ||
|Atrium Health | |Atrium Health | ||
|- | |- | ||
|Jennifer | |Jennifer | ||
| Line 178: | Line 166: | ||
|Nguyen | |Nguyen | ||
|GeneDx | |GeneDx | ||
|- | |||
|Jieying | |||
|Chu | |||
|NeoGenomics Laboratories | |||
|- | |||
|Hannah | |||
|Wollenzien | |||
|Sanford Health | |||
|} | |} | ||